D-K6L9
General Information
DCTPep ID DCTPep00157
Peptide Name D-K6L9
Sequence LKlLKKLlkKLLkLL
Sequence Length 15
UniProt ID Not available
PubChem CID Not available
Origin Host Defense lytic Peptide
Type Synthetic peptide
Classification
ACP Tumor active peptide Cancer targeted peptides
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
CL-1 | Canine leukemia | LC50=3 μmol/L | ELISA assay | Not available | 1 |
MDA-MB-231 | Breast adenocarcinoma | LC50=3 μmol/L | ELISA assay | Not available | 1 |
22Rv1 | Prostate carcinoma | LC50=6 μmol/L | ELISA assay | Not available | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target surface phosphatidylserine
Affinity Not available
Mechanism The exclusive selectivity of the peptide towards cancer derives from its specific binding to surface phosphatidylserine and the killing of the cancer cells via cytoplasmic membrane depolarization
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification l=D-Leucine; k=D-Lysine
Chiral Mix
Physicochemical Information
Formula Not Applicable
Absent amino acids Not Applicable
Theoretical pI Not Applicable
Acidic residues Not Applicable
Basic residues Not Applicable
Polar residues Not Applicable
Molecular weight (Average) Not Applicable
Molecular weight (Monoisotopic) Not Applicable
Common amino acids Not Applicable
Net charge Not Applicable
Instability index (II) Not Applicable
Aliphatic index Not Applicable
Grand average of hydropathicity (GRAVY) Not Applicable
Half Life
Not Applicable
Extinction coefficients
Not Applicable
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 16707464
Title Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide
Doi 10.1158/0008-5472.CAN-05-4569
Year 2006
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available